MOLBIO · Healthcare · Medical Devices
| Share price | ₹1,094.00 |
| P/B ratio | 10.6 |
| ROE | 17.8% |
| ROCE | 16.5% |
| Book value | ₹103.67 |
| Year | Sales | Net profit | OPM |
|---|---|---|---|
| 2026 | ₹1,415 Cr | ₹167 Cr | 19.7% |
| 2025 | ₹997 Cr | ₹145 Cr | 23.0% |
| 2024 | ₹820 Cr | ₹102 Cr | 26.1% |
| 2023 | ₹322 Cr | ₹-1 Cr | 4.2% |
Molbio Diagnostics Limited, a point-of-care diagnostics company, provides healthcare technologies to diagnose infectious and non-communicable diseases. It manufactures and sells chip based diagnostic devices, chips and reagents, X-ray equipment's, and single/dual detectors. It also offers disposable POCT devices, which includes dengue, malaria, and COVID-19 tests; Tabletop analysers, a portable machine that are used to perform molecular or immunodiagnostic tests to detect infectious diseases, such as tuberculosis, human papillomavrus, STIs, and GI disorders. In addition, the company offers Tru